Global Influenza Vaccination Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches.

    Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.

    The Influenza Vaccination is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period. The research provides insights for the global Influenza Vaccination market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Influenza Vaccination industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Influenza Vaccination Market Segmentations:

    By Players:

    • Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • Sanofi (Europe)

    • F Hoffmann-La Roche Ltd (Europe)

    • Novartis AG (Europe)

    • Abbott (US)

    • GlaxoSmithKline plc (Europe)

    • Hualan Biological Engineering Inc (Asia Pacific)

    • BioCryst Pharmaceuticals, Inc (US)

    • DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • AstraZeneca (Europe)

    By Types:

    • Egg Based

    • Cell Culture

    • Recombinant

    By End-User:

    • Hospitals

    • Research Organizations

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Influenza Vaccination Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Influenza Vaccination Market Size and Growth Rate of Egg Based from 2014 to 2026

      • 1.3.2 Global Influenza Vaccination Market Size and Growth Rate of Cell Culture from 2014 to 2026

      • 1.3.3 Global Influenza Vaccination Market Size and Growth Rate of Recombinant from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Influenza Vaccination Market Size and Growth Rate of Hospitals from 2014 to 2026

      • 1.4.2 Global Influenza Vaccination Market Size and Growth Rate of Research Organizations from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Influenza Vaccination Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Influenza Vaccination Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Influenza Vaccination by Major Types

      • 3.4.1 Influenza Vaccination Market Size and Growth Rate of Egg Based

      • 3.4.2 Influenza Vaccination Market Size and Growth Rate of Cell Culture

      • 3.4.3 Influenza Vaccination Market Size and Growth Rate of Recombinant

    4 Segmentation of Influenza Vaccination Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Influenza Vaccination by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Influenza Vaccination in Hospitals

      • 4.4.2 Market Size and Growth Rate of Influenza Vaccination in Research Organizations

    5 Market Analysis by Major Regions

    • 5.1 Global Influenza Vaccination Production Analysis by Major Regions

    • 5.2 Global Influenza Vaccination Consumption Analysis by Major Regions

    • 5.3 Global Influenza Vaccination Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Influenza Vaccination Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Influenza Vaccination Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Influenza Vaccination Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Influenza Vaccination Production, Import, Consumption and Export Analysis

    6 Product Commodity of Influenza Vaccination Market in Major Countries

    • 6.1 Top 5 Export Countries in Influenza Vaccination market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Influenza Vaccination market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Influenza Vaccination market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Influenza Vaccination market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Influenza Vaccination market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Influenza Vaccination market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Influenza Vaccination Landscape Analysis

    • 7.1 North America Influenza Vaccination Landscape Analysis by Major Types

    • 7.2 North America Influenza Vaccination Landscape Analysis by Major End-Users

    • 7.3 North America Influenza Vaccination Landscape Analysis by Major Countries

      • 7.3.1 United States Influenza Vaccination Market Volume and Growth Rate

      • 7.3.2 Canada Influenza Vaccination Market Volume and Growth Rate

      • 7.3.3 Mexico Influenza Vaccination Market Volume and Growth Rate

    8 Europe Influenza Vaccination Landscape Analysis

    • 8.1 Europe Influenza Vaccination Landscape Analysis by Major Types

    • 8.2 Europe Influenza Vaccination Landscape Analysis by Major End-Users

    • 8.3 Europe Influenza Vaccination Landscape Analysis by Major Countries

      • 8.3.1 Germany Influenza Vaccination Market Volume and Growth Rate

      • 8.3.2 UK Influenza Vaccination Market Volume and Growth Rate

      • 8.3.3 France Influenza Vaccination Market Volume and Growth Rate

      • 8.3.4 Italy Influenza Vaccination Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Influenza Vaccination Market Volume and Growth Rate

      • 8.3.6 Spain Influenza Vaccination Market Volume and Growth Rate

      • 8.3.7 Belgium Influenza Vaccination Market Volume and Growth Rate

      • 8.3.8 Poland Influenza Vaccination Market Volume and Growth Rate

      • 8.3.9 Russia Influenza Vaccination Market Volume and Growth Rate

      • 8.3.10 Turkey Influenza Vaccination Market Volume and Growth Rate

    9 Asia Pacific Influenza Vaccination Landscape Analysis

    • 9.1 Asia Pacific Influenza Vaccination Landscape Analysis by Major Types

    • 9.2 Asia Pacific Influenza Vaccination Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Influenza Vaccination Landscape Analysis by Major Countries

      • 9.3.1 China Influenza Vaccination Market Volume and Growth Rate

      • 9.3.2 Japan Influenza Vaccination Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Influenza Vaccination Market Volume and Growth Rate

      • 9.3.4 India Influenza Vaccination Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Influenza Vaccination Market Volume and Growth Rate

      • 9.3.6 South Korea Influenza Vaccination Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Influenza Vaccination Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Influenza Vaccination Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Influenza Vaccination Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Influenza Vaccination Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Influenza Vaccination Market Volume and Growth Rate

      • 10.3.2 Brazil Influenza Vaccination Market Volume and Growth Rate

      • 10.3.3 Nigeria Influenza Vaccination Market Volume and Growth Rate

      • 10.3.4 South Africa Influenza Vaccination Market Volume and Growth Rate 

      • 10.3.5 Argentina Influenza Vaccination Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

      • 11.1.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Sanofi (Europe)

      • 11.2.1 Sanofi (Europe) Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 F Hoffmann-La Roche Ltd (Europe)

      • 11.3.1 F Hoffmann-La Roche Ltd (Europe) Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Novartis AG (Europe)

      • 11.4.1 Novartis AG (Europe) Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Abbott (US)

      • 11.5.1 Abbott (US) Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 GlaxoSmithKline plc (Europe)

      • 11.6.1 GlaxoSmithKline plc (Europe) Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Hualan Biological Engineering Inc (Asia Pacific)

      • 11.7.1 Hualan Biological Engineering Inc (Asia Pacific) Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 BioCryst Pharmaceuticals, Inc (US)

      • 11.8.1 BioCryst Pharmaceuticals, Inc (US) Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

      • 11.9.1 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 AstraZeneca (Europe)

      • 11.10.1 AstraZeneca (Europe) Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 84 Figures and 130 Tables)

    • Figure Product Picture

    • Figure Influenza Vaccination Market Size and Growth Rate of Egg Based from 2014 to 2026

    • Figure Influenza Vaccination Market Size and Growth Rate of Cell Culture from 2014 to 2026

    • Figure Influenza Vaccination Market Size and Growth Rate of Recombinant from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Influenza Vaccination Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Global Influenza Vaccination Market Size and Growth Rate of Research Organizations from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Influenza Vaccination Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Influenza Vaccination Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Influenza Vaccination

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Influenza Vaccination by Different Types from 2014 to 2026

    • Table Consumption Share of Influenza Vaccination by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Egg Based

    • Figure Market Size and Growth Rate of Cell Culture

    • Figure Market Size and Growth Rate of Recombinant

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Influenza Vaccination by Different End-Users from 2014 to 2026

    • Table Consumption Share of Influenza Vaccination by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Research Organizations

    • Table Global Influenza Vaccination Production by Major Regions

    • Table Global Influenza Vaccination Production Share by Major Regions

    • Figure Global Influenza Vaccination Production Share by Major Regions in 2014

    • Figure Global Influenza Vaccination Production Share by Major Regions in 2018

    • Figure Global Influenza Vaccination Production Share by Major Regions in 2026

    • Table Global Influenza Vaccination Consumption by Major Regions

    • Table Global Influenza Vaccination Consumption Share by Major Regions

    • Figure Global Influenza Vaccination Consumption Share by Major Regions in 2014

    • Figure Global Influenza Vaccination Consumption Share by Major Regions in 2018

    • Figure Global Influenza Vaccination Consumption Share by Major Regions in 2026

    • Table North America Influenza Vaccination Production, Import, Consumption and Export Analysis

    • Table Europe Influenza Vaccination Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Influenza Vaccination Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Influenza Vaccination Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Influenza Vaccination market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Influenza Vaccination market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Influenza Vaccination market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Influenza Vaccination market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Influenza Vaccination Consumption by Types from 2014 to 2026

    • Table North America Influenza Vaccination Consumption Share by Types from 2014 to 2026

    • Figure North America Influenza Vaccination Consumption Share by Types in 2014

    • Figure North America Influenza Vaccination Consumption Share by Types in 2018

    • Figure North America Influenza Vaccination Consumption Share by Types in 2026

    • Table North America Influenza Vaccination Consumption by End-Users from 2014 to 2026

    • Table North America Influenza Vaccination Consumption Share by End-Users from 2014 to 2026

    • Figure North America Influenza Vaccination Consumption Share by End-Users in 2014

    • Figure North America Influenza Vaccination Consumption Share by End-Users in 2018

    • Figure North America Influenza Vaccination Consumption Share by End-Users in 2026

    • Table North America Influenza Vaccination Consumption by Major Countries from 2014 to 2026

    • Table North America Influenza Vaccination Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Influenza Vaccination Consumption Share by Major Countries in 2014

    • Figure North America Influenza Vaccination Consumption Share by Major Countries in 2018

    • Figure North America Influenza Vaccination Consumption Share by Major Countries in 2026

    • Figure United States Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Influenza Vaccination Consumption by Types from 2014 to 2026

    • Table Europe Influenza Vaccination Consumption Share by Types from 2014 to 2026

    • Figure Europe Influenza Vaccination Consumption Share by Types in 2014

    • Figure Europe Influenza Vaccination Consumption Share by Types in 2018

    • Figure Europe Influenza Vaccination Consumption Share by Types in 2026

    • Table Europe Influenza Vaccination Consumption by End-Users from 2014 to 2026

    • Table Europe Influenza Vaccination Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Influenza Vaccination Consumption Share by End-Users in 2014

    • Figure Europe Influenza Vaccination Consumption Share by End-Users in 2018

    • Figure Europe Influenza Vaccination Consumption Share by End-Users in 2026

    • Table Europe Influenza Vaccination Consumption by Major Countries from 2014 to 2026

    • Table Europe Influenza Vaccination Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Influenza Vaccination Consumption Share by Major Countries in 2014

    • Figure Europe Influenza Vaccination Consumption Share by Major Countries in 2018

    • Figure Europe Influenza Vaccination Consumption Share by Major Countries in 2026

    • Figure Germany Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure France Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Influenza Vaccination Consumption by Types from 2014 to 2026

    • Table Asia Pacific Influenza Vaccination Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Influenza Vaccination Consumption Share by Types in 2014

    • Figure Asia Pacific Influenza Vaccination Consumption Share by Types in 2018

    • Figure Asia Pacific Influenza Vaccination Consumption Share by Types in 2026

    • Table Asia Pacific Influenza Vaccination Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Influenza Vaccination Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Influenza Vaccination Consumption Share by End-Users in 2014

    • Figure Asia Pacific Influenza Vaccination Consumption Share by End-Users in 2018

    • Figure Asia Pacific Influenza Vaccination Consumption Share by End-Users in 2026

    • Table Asia Pacific Influenza Vaccination Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Influenza Vaccination Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Influenza Vaccination Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Influenza Vaccination Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Influenza Vaccination Consumption Share by Major Countries in 2026

    • Figure China Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandInfluenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure India Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Influenza Vaccination Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Influenza Vaccination Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Influenza Vaccination Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Influenza Vaccination Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Influenza Vaccination Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Influenza Vaccination Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Influenza Vaccination Consumption Share by Major Countries in 2026

    • Figure GCC Countries Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Influenza Vaccination Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • Figure Sales and Growth Rate Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • Figure Revenue and Market Share Analysis of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • Table Product and Service Introduction of Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • Table Company Profile and Development Status of Sanofi (Europe)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi (Europe)

    • Figure Sales and Growth Rate Analysis of Sanofi (Europe)

    • Figure Revenue and Market Share Analysis of Sanofi (Europe)

    • Table Product and Service Introduction of Sanofi (Europe)

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd (Europe)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd (Europe)

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd (Europe)

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd (Europe)

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd (Europe)

    • Table Company Profile and Development Status of Novartis AG (Europe)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Europe)

    • Figure Sales and Growth Rate Analysis of Novartis AG (Europe)

    • Figure Revenue and Market Share Analysis of Novartis AG (Europe)

    • Table Product and Service Introduction of Novartis AG (Europe)

    • Table Company Profile and Development Status of Abbott (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott (US)

    • Figure Sales and Growth Rate Analysis of Abbott (US)

    • Figure Revenue and Market Share Analysis of Abbott (US)

    • Table Product and Service Introduction of Abbott (US)

    • Table Company Profile and Development Status of GlaxoSmithKline plc (Europe)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc (Europe)

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc (Europe)

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc (Europe)

    • Table Product and Service Introduction of GlaxoSmithKline plc (Europe)

    • Table Company Profile and Development Status of Hualan Biological Engineering Inc (Asia Pacific)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Biological Engineering Inc (Asia Pacific)

    • Figure Sales and Growth Rate Analysis of Hualan Biological Engineering Inc (Asia Pacific)

    • Figure Revenue and Market Share Analysis of Hualan Biological Engineering Inc (Asia Pacific)

    • Table Product and Service Introduction of Hualan Biological Engineering Inc (Asia Pacific)

    • Table Company Profile and Development Status of BioCryst Pharmaceuticals, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCryst Pharmaceuticals, Inc (US)

    • Figure Sales and Growth Rate Analysis of BioCryst Pharmaceuticals, Inc (US)

    • Figure Revenue and Market Share Analysis of BioCryst Pharmaceuticals, Inc (US)

    • Table Product and Service Introduction of BioCryst Pharmaceuticals, Inc (US)

    • Table Company Profile and Development Status of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • Figure Sales and Growth Rate Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • Figure Revenue and Market Share Analysis of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • Table Product and Service Introduction of DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • Table Company Profile and Development Status of AstraZeneca (Europe)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca (Europe)

    • Figure Sales and Growth Rate Analysis of AstraZeneca (Europe)

    • Figure Revenue and Market Share Analysis of AstraZeneca (Europe)

    • Table Product and Service Introduction of AstraZeneca (Europe)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.